Clinical Trial Update: Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis [NA]

View source ↗

Summary

A completed clinical trial comparing OSTENIL PLUS and Synvisc-One in tibiofemoral knee osteoarthritis reports on their efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Ostenil Plus (sodium hyaluronate)
• Synvisc-One (hylan G-F 20)

Snippet

Sponsor: TRB Chemedica | Conditions: Knee Osteoarthritis | NA | Status: COMPLETED